Morgan Stanley’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $512 | Sell |
852
-1,316
| -61% | -$791 | ﹤0.01% | 7446 |
|
|
2025
Q1 | $585 | Sell |
2,168
-15,029
| -87% | -$4.06K | ﹤0.01% | 7349 |
|
|
2024
Q4 | $8.94K | Sell |
17,197
-20,680
| -55% | -$10.8K | ﹤0.01% | 6845 |
|
|
2024
Q3 | $123K | Sell |
37,877
-8,299
| -18% | -$26.9K | ﹤0.01% | 5922 |
|
|
2024
Q2 | $139K | Sell |
46,176
-74,338
| -62% | -$223K | ﹤0.01% | 5836 |
|
|
2024
Q1 | $560K | Sell |
120,514
-59,706
| -33% | -$278K | ﹤0.01% | 5263 |
|
|
2023
Q4 | $746K | Buy |
180,220
+56,883
| +46% | +$235K | ﹤0.01% | 5442 |
|
|
2023
Q3 | $370K | Sell |
123,337
-79,400
| -39% | -$238K | ﹤0.01% | 5305 |
|
|
2023
Q2 | $499K | Sell |
202,737
-145,137
| -42% | -$357K | ﹤0.01% | 5214 |
|
|
2023
Q1 | $786K | Sell |
347,874
-140,865
| -29% | -$318K | ﹤0.01% | 4999 |
|
|
2022
Q4 | $1.71M | Buy |
488,739
+196,129
| +67% | +$684K | ﹤0.01% | 4557 |
|
|
2022
Q3 | $10.8M | Sell |
292,610
-22,627
| -7% | -$838K | ﹤0.01% | 2877 |
|
|
2022
Q2 | $5.99M | Buy |
315,237
+49,172
| +18% | +$934K | ﹤0.01% | 3596 |
|
|
2022
Q1 | $7.18M | Sell |
266,065
-307,256
| -54% | -$8.29M | ﹤0.01% | 3284 |
|
|
2021
Q4 | $12.9M | Buy |
573,321
+123,980
| +28% | +$2.79M | ﹤0.01% | 2643 |
|
|
2021
Q3 | $11.8M | Buy |
449,341
+422,982
| +1,605% | +$11.1M | ﹤0.01% | 2700 |
|
|
2021
Q2 | $844K | Buy |
26,359
+25,205
| +2,184% | +$807K | ﹤0.01% | 5184 |
|
|
2021
Q1 | $41K | Sell |
1,154
-10,462
| -90% | -$372K | ﹤0.01% | 6438 |
|
|
2020
Q4 | $373K | Sell |
11,616
-1,828
| -14% | -$58.7K | ﹤0.01% | 5252 |
|
|
2020
Q3 | $506K | Sell |
13,444
-32,443
| -71% | -$1.22M | ﹤0.01% | 4638 |
|
|
2020
Q2 | $2.05M | Buy |
45,887
+45,111
| +5,813% | +$2.02M | ﹤0.01% | 3569 |
|
|
2020
Q1 | $26K | Sell |
776
-5,972
| -89% | -$200K | ﹤0.01% | 5716 |
|
|
2019
Q4 | $263K | Buy |
+6,748
| New | +$263K | ﹤0.01% | 5293 |
|